---
title: "Aortic Surgery"
order: 4
category: "Cardiac Surgery"
---

# Aortic Surgery

## Overview

Aortic surgery addresses pathology of the thoracic and thoracoabdominal aorta, including aneurysms, dissections, traumatic injuries, and aortic arch anomalies. The evolution of endovascular techniques has expanded treatment options, offering less invasive alternatives to traditional open repair in select patients. Understanding aortic anatomy, pathophysiology, imaging, and the spectrum of surgical and endovascular interventions is essential for managing these life-threatening conditions.

## Aortic Anatomy

### Segments of the Aorta

**Thoracic Aorta**
- **Aortic root**: Aortic valve annulus, sinuses of Valsalva, sinotubular junction
- **Ascending aorta**: From sinotubular junction to innominate artery origin
- **Aortic arch**: Innominate (brachiocephalic), left common carotid, left subclavian arteries
- **Descending thoracic aorta**: From left subclavian artery to diaphragm

**Abdominal Aorta**
- From diaphragm to aortic bifurcation (iliac arteries)
- Visceral branches: Celiac, superior mesenteric, renal arteries
- Infrarenal aorta: Below renal arteries (most common site for AAA)

**Thoracoabdominal Aorta**
- Extends from left subclavian to aortic bifurcation
- Crawford classification (Types I-V) based on extent

### Normal Dimensions

**Thoracic Aorta (Adults)**
- Aortic root: 2.0-3.7 cm
- Ascending aorta: 2.0-3.7 cm
- Aortic arch: 2.0-3.6 cm
- Descending thoracic aorta: 2.0-3.0 cm

**Abdominal Aorta**
- Suprarenal: 2.0-2.5 cm
- Infrarenal: 1.5-2.0 cm

**Aneurysm Definition**: Diameter ≥50% greater than normal (typically ≥3 cm ascending aorta, ≥4 cm descending thoracic aorta, ≥3 cm abdominal aorta)

## Aortic Aneurysms

### Pathophysiology

**Etiology**

**Degenerative (Most Common)**
- Atherosclerosis
- Medial degeneration, cystic medial necrosis
- Age-related elastic fiber degradation

**Genetic/Connective Tissue Disorders**
- **Marfan syndrome**: Fibrillin-1 mutation, aortic root dilatation
- **Loeys-Dietz syndrome**: TGF-β receptor mutations, aggressive aortic disease
- **Ehlers-Danlos syndrome** (vascular type): Collagen III deficiency, arterial rupture
- **Bicuspid aortic valve (BAV)**: Associated aortopathy (30-50% have aortic dilatation)
- **Familial thoracic aortic aneurysm (FTAA)**

**Inflammatory**
- Takayasu arteritis, giant cell arteritis
- Aortic vasculitis

**Infectious (Mycotic Aneurysm)**
- Bacterial (S. aureus, Salmonella), fungal
- Direct infection of aortic wall

**Traumatic**
- Blunt trauma, pseudoaneurysm

**Risk Factors**
- Hypertension (most important modifiable risk factor)
- Smoking
- Advanced age
- Male gender
- Family history

### Clinical Presentation

**Asymptomatic**
- Most aneurysms discovered incidentally on imaging

**Symptomatic**
- **Thoracic aortic aneurysm (TAA)**:
  - Chest or back pain
  - Compression: Dysphagia (esophagus), hoarseness (recurrent laryngeal nerve), dyspnea (trachea/bronchus)
  - Aortic regurgitation (ascending aortic aneurysm)
- **Abdominal aortic aneurysm (AAA)**:
  - Abdominal/back pain
  - Palpable pulsatile abdominal mass
  - Compression: GI symptoms, ureteral obstruction

**Rupture**
- Sudden severe chest/back pain, hypotension, shock
- **High mortality**: >50% before reaching hospital, >50% operative mortality

### Natural History and Indications for Repair

**Growth Rate**
- **Ascending aorta**: ~0.1 cm/year (faster in Marfan, BAV)
- **Descending thoracic aorta**: ~0.3 cm/year
- **Abdominal aorta**: ~0.2-0.3 cm/year

**Rupture Risk**
- Increases exponentially with size
- **TAA rupture risk**:
  - 4-5.9 cm: 2% per year
  - 6-6.9 cm: 7% per year
  - ≥7 cm: 14% per year
- **AAA rupture risk**:
  - 5-5.9 cm: 1% per year
  - 6-6.9 cm: 10% per year
  - ≥7 cm: 30% per year

**Indications for Elective Repair**

**Ascending Aorta/Aortic Root**
- **≥5.5 cm** (general population)
- **≥5.0 cm** (Marfan, Loeys-Dietz, BAV, family history of dissection)
- **≥4.5 cm** (Loeys-Dietz, rapid growth >0.5 cm/year)
- **Undergoing aortic valve surgery**: ≥4.5 cm

**Descending Thoracic Aorta**
- **≥6.0 cm** (general population)
- **≥5.5 cm** (connective tissue disorder)

**Abdominal Aorta**
- **≥5.5 cm** (men), **≥5.0 cm** (women)
- **Rapid growth** >0.5 cm/6 months
- **Symptomatic** (any size)

## Ascending Aorta and Aortic Root Surgery

### Ascending Aortic Aneurysm Repair (Supracoronary Graft)

**Indications**
- Ascending aortic aneurysm with normal aortic root and valve

**Operative Technique**
1. **Median sternotomy**
2. **Cardiopulmonary bypass**: Aortic (distal arch or femoral artery) and right atrial cannulation
3. **Cooling**: Moderate hypothermia (28-32°C)
4. **Cross-clamp aorta, cardioplegia**
5. **Transect ascending aorta**: Above sinotubular junction, below innominate artery
6. **Excise aneurysmal aorta**
7. **Interposition graft**: Dacron tube graft (24-30 mm), proximal and distal anastomoses
8. **Rewarm, wean CPB**

**Outcomes**
- Mortality: 2-4%
- Excellent long-term durability

### Aortic Root Replacement (Composite Graft, Bentall Procedure)

**Indications**
- Aortic root aneurysm with aortic valve disease
- Marfan syndrome with root dilatation

**Operative Technique**
1. **Median sternotomy, CPB**
2. **Cardioplegia, cross-clamp**
3. **Open aortic root**
4. **Excise aortic valve and root**
5. **Composite graft implantation**:
   - Dacron tube graft with mechanical or bioprosthetic valve sewn in
   - Suture graft to aortic annulus
6. **Coronary artery reimplantation**:
   - **Buttons of coronary ostia** excised from aortic root
   - Reimplanted into holes in Dacron graft
7. **Distal anastomosis**: Graft to ascending aorta
8. **Wean CPB**

**Outcomes**
- Mortality: 3-6%
- Long-term: Excellent graft durability, valve-related complications (mechanical: anticoagulation, bioprosthetic: SVD)

### Valve-Sparing Root Replacement (David or Yacoub Procedure)

**Indications**
- Aortic root aneurysm with **normal or near-normal aortic valve**
- Younger patients who wish to avoid prosthetic valve and anticoagulation
- **Contraindications**: Severe leaflet abnormalities, calcification, severe regurgitation

**David Procedure (Reimplantation)**
- **Most common valve-sparing technique**
- Aortic valve and coronary ostia reimplanted into Dacron graft

**Operative Steps**
1. **Median sternotomy, CPB**
2. **Transect aorta above sinotubular junction**
3. **Excise aortic sinuses**: Preserve valve leaflets and annulus
4. **Dacron graft**: Pass graft over valve, suture to annulus
5. **Reimplant coronary arteries** into graft
6. **Distal anastomosis**
7. **Wean CPB, assess valve** (TEE)

**Yacoub Procedure (Remodeling)**
- Replace sinuses with Dacron graft, preserve native annulus
- Less commonly used (higher recurrent AR vs. David)

**Outcomes**
- Mortality: 2-4%
- Freedom from reoperation: 85-90% at 10 years
- Advantages: Avoid prosthetic valve complications
- Complications: Recurrent AR (5-15% at 10 years, higher in Marfan)

## Aortic Arch Surgery

### Indications

- Aortic arch aneurysm ≥6.0 cm
- Arch involvement in dissection
- Traumatic arch injury
- Arch anomalies (coarctation, vascular rings)

### Challenges

- **Cerebral perfusion**: Arch vessels supply brain, require specialized perfusion strategies
- **Technical complexity**: Multiple anastomoses, hypothermic circulatory arrest

### Operative Techniques

**Cerebral Protection Strategies**

**Hypothermic Circulatory Arrest (HCA)**
- Cool to **18-20°C** (deep hypothermia)
- Stop CPB, open arch
- Safe arrest time: 30-40 minutes at 18°C
- **Cerebral protection**: Hypothermia reduces metabolic demand

**Antegrade Cerebral Perfusion (ACP)**
- Cannulate arch vessels (innominate, left carotid arteries)
- Perfuse brain during arch reconstruction
- Allows **moderate hypothermia** (24-28°C), longer safe circulatory arrest time
- **Preferred method** (lower stroke risk vs. HCA alone)

**Retrograde Cerebral Perfusion (RCP)**
- Perfuse brain via SVC
- Less effective than ACP
- Adjunct to HCA

**Total Arch Replacement**

**Steps**
1. **Median sternotomy, CPB**
2. **Cooling to 24-28°C** (moderate hypothermia with ACP) or 18-20°C (deep HCA)
3. **Circulatory arrest**
4. **Open arch, excise aneurysm**
5. **Distal anastomosis**: Dacron graft to descending aorta
6. **Reimplant arch vessels**:
   - **Island technique**: Arch vessels on single patch of aorta, reimplant together
   - **Separate grafts**: Individual grafts to each arch vessel (innominate, left carotid, left subclavian)
7. **Proximal anastomosis**: Graft to ascending aorta
8. **Resume CPB, rewarm**
9. **Wean CPB**

**Hemiarch Replacement**
- Partial arch replacement (lesser curve, proximal arch)
- Less extensive than total arch
- Lower stroke risk, shorter circulatory arrest

**Outcomes**
- **Total arch mortality**: 5-15%
- **Stroke risk**: 3-10%
- **Spinal cord ischemia**: 1-5%

## Descending Thoracic and Thoracoabdominal Aortic Surgery

### Open Repair

**Indications**
- Thoracic or thoracoabdominal aortic aneurysm ≥6.0 cm
- Unsuitable anatomy for endovascular repair
- Young, low-risk patients

**Operative Approach**
- **Left posterolateral thoracotomy**: 4th-6th intercostal space
- **Thoracoabdominal incision**: Extends into abdomen (for thoracoabdominal aneurysms)

**Technique**
1. **Exposure**: Left lung retraction, expose descending aorta
2. **Proximal aortic control**: Clamp proximal aorta
3. **Distal aortic control**: Clamp distal aorta
4. **Graft interposition**:
   - Open aorta, Dacron tube graft
   - Proximal and distal anastomoses
5. **Reimplant intercostal arteries** (T8-L1, critical for spinal cord perfusion)
6. **Reimplant visceral arteries** (celiac, SMA, renals) if thoracoabdominal
7. **Closure**

**Spinal Cord Protection**
- **Critical issue**: Anterior spinal artery perfusion
- **Strategies**:
  - **Reimplant intercostal arteries** (T8-L1)
  - **Cerebrospinal fluid (CSF) drainage**: Lower CSF pressure, improve spinal perfusion
  - **Distal aortic perfusion**: Left heart bypass, partial CPB
  - **Motor evoked potentials (MEPs)**: Intraoperative monitoring
  - **Moderate hypothermia**: 32-34°C

**Crawford Classification** (Thoracoabdominal Aneurysms)
- **Type I**: Distal arch to suprarenal aorta
- **Type II**: Distal arch to aortic bifurcation (entire thoracoabdominal aorta, highest paraplegia risk)
- **Type III**: Lower descending thoracic aorta to aortic bifurcation
- **Type IV**: Diaphragm to aortic bifurcation (entire abdominal aorta)
- **Type V**: Lower descending thoracic aorta to suprarenal aorta

**Complications**
- **Spinal cord ischemia/paraplegia**: 5-15% (higher for Type II)
- **Renal failure**: 5-10%
- **Stroke**: 2-5%
- **Mortality**: 5-20% (depends on extent, patient comorbidities)

### Endovascular Repair (TEVAR)

**Thoracic Endovascular Aortic Repair**

**Indications**
- Descending thoracic aortic aneurysm ≥6.0 cm (≥5.5 cm in connective tissue disorder)
- High-risk patients unsuitable for open repair
- Traumatic aortic injury
- Complicated type B aortic dissection

**Anatomy Requirements**
- Adequate **proximal landing zone** (≥2 cm healthy aorta distal to left subclavian artery)
- Adequate **distal landing zone** (≥2 cm healthy aorta proximal to celiac artery)
- Adequate access vessels (iliac/femoral arteries ≥7-8 mm, not severely tortuous/calcified)

**Procedure**
1. **Femoral artery access**: Percutaneous or open cut-down
2. **Guidewire and catheter**: Navigate to thoracic aorta
3. **Stent-graft deployment**:
   - Position across aneurysm, covering proximal and distal landing zones
   - Deploy stent-graft (self-expanding or balloon-expandable)
4. **Balloon angioplasty**: Ensure apposition to aortic wall
5. **Completion angiography**: Assess for endoleaks
6. **Closure**: Percutaneous closure device or surgical repair

**Left Subclavian Artery Coverage**
- Often necessary for adequate proximal seal
- **Revascularization**: Carotid-subclavian bypass or transposition (prevent stroke, spinal cord ischemia, arm ischemia)
- Debate: Routine vs. selective revascularization

**Complications**
- **Endoleak**:
  - **Type I**: Perigraft leak at proximal or distal landing zone (requires reintervention)
  - **Type II**: Retrograde flow from intercostal/lumbar arteries (often benign, observe)
  - **Type III**: Graft fabric tear or modular separation (requires reintervention)
  - **Type IV**: Graft porosity (rare, usually resolves)
- **Stroke**: 2-5% (embolic debris, arch vessel coverage)
- **Spinal cord ischemia**: 3-8% (coverage of intercostal arteries, especially T8-L1)
- **Access complications**: Vascular injury, dissection, bleeding
- **Stent-graft migration**: Inadequate fixation
- **Retrograde type A dissection**: <1%, catastrophic

**Outcomes**
- **TEVAR mortality**: 2-5% (30-day)
- Lower morbidity vs. open repair (shorter hospital stay, less pain, faster recovery)
- Long-term: Requires surveillance imaging (CT every 6-12 months), endoleak monitoring, reintervention rate 10-20% at 5 years

## Aortic Dissection

### Pathophysiology

**Definition**
- Tear in aortic intima → blood enters media → creates false lumen
- **True lumen**: Original aortic channel, lined by intima
- **False lumen**: Dissection channel in media, may thrombose or remain patent

**Etiology**
- **Hypertension**: Most important risk factor (70-80% of patients)
- **Connective tissue disorders**: Marfan, Loeys-Dietz, Ehlers-Danlos
- **Bicuspid aortic valve**, aortic coarctation
- **Trauma**
- **Pregnancy** (increased risk in 3rd trimester, peripartum)
- **Cocaine use**, stimulants
- **Iatrogenic**: Cardiac catheterization, cardiac surgery

**Classification**

**Stanford Classification**
- **Type A**: Involves ascending aorta (regardless of origin)
  - **Surgical emergency**
  - 60% of dissections
- **Type B**: Does not involve ascending aorta (descending aorta only)
  - **Medical management** (unless complicated)
  - 40% of dissections

**DeBakey Classification**
- **Type I**: Originates in ascending aorta, extends to arch and descending aorta
- **Type II**: Confined to ascending aorta
- **Type III**: Originates in descending aorta
  - **IIIa**: Descending thoracic aorta only
  - **IIIb**: Extends below diaphragm

### Clinical Presentation

**Symptoms**
- **Sudden, severe chest/back pain**: "Tearing," "ripping" quality
  - **Type A**: Anterior chest pain
  - **Type B**: Interscapular back pain
- Pain may migrate as dissection propagates
- **Syncope** (10-15%): Cardiac tamponade, stroke, hypotension

**Complications**

**Type A Dissection**
- **Aortic regurgitation**: Dissection disrupts aortic valve commissures
- **Cardiac tamponade**: Rupture into pericardium
- **Myocardial infarction**: Coronary artery dissection (usually RCA)
- **Stroke**: Arch vessel involvement
- **Shock, death**: Aortic rupture

**Type B Dissection**
- **Malperfusion syndromes**: False lumen compresses true lumen, compromises branch vessels
  - **Visceral ischemia**: Celiac, SMA (abdominal pain, bowel ischemia)
  - **Renal ischemia**: Renal artery (acute kidney injury, hypertension)
  - **Lower extremity ischemia**: Iliac artery (claudication, limb ischemia)
  - **Spinal cord ischemia**: Intercostal artery (paraplegia)
- **Rupture**: Free rupture (hemothorax, death), contained rupture

**Physical Examination**
- **Blood pressure discrepancy** between arms (>20 mmHg, arch vessel involvement)
- **Pulse deficits**: Decreased pulses (carotid, radial, femoral)
- **Aortic regurgitation murmur** (diastolic murmur, type A)
- **Hypotension**: Tamponade, shock
- **Neurologic deficits**: Stroke, spinal cord ischemia

### Diagnosis

**Imaging**

**CT Angiography (CTA)**
- **Gold standard** for diagnosis
- Shows: Intimal flap, true and false lumens, extent of dissection, branch vessel involvement
- **Sensitivity/specificity**: >95%

**Transesophageal Echocardiography (TEE)**
- **Rapid bedside diagnosis** (especially for unstable type A patients in OR)
- Excellent for ascending aorta, arch (limited view of descending aorta)
- Assess: Aortic regurgitation, pericardial effusion, ventricular function

**MRI/MRA**
- Excellent imaging, no radiation/contrast
- **Limited availability**, time-consuming (not for unstable patients)

**Chest X-Ray**
- **Widened mediastinum**: Suggestive but non-specific
- Normal CXR does not exclude dissection

**Biomarkers**
- **D-dimer**: High sensitivity (negative D-dimer makes dissection unlikely), low specificity
- Troponin: Elevated if MI complicates dissection

### Management

**Type A Dissection (Surgical Emergency)**

**Medical Stabilization**
- **Blood pressure control**: Target SBP 100-120 mmHg, HR <60 bpm
  - **Beta-blockers** (labetalol, esmolol): First-line (reduce shear stress)
  - **Vasodilators** (nitroprusside): Only after beta-blockade (avoid reflex tachycardia)
- **Pain control**: Opioids
- **Avoid anticoagulation**: Risk of hemorrhagic complications

**Emergent Surgery**
- **Goal**: Resect intimal tear, prevent rupture, restore true lumen flow
- **Operative technique**:
  1. Median sternotomy, CPB (femoral arterial cannulation if aortic involvement severe)
  2. Hypothermic circulatory arrest (if arch involved)
  3. Open ascending aorta, identify intimal tear
  4. Resect ascending aorta (and arch if involved)
  5. **Graft interposition**: Dacron graft replacing ascending aorta ± arch
  6. **Aortic valve**: Resuspend if AR (valve-sparing), replace if valve destroyed
  7. Wean CPB
- **Extent**: Replace ascending aorta always; extend to arch (hemiarch, total arch) if tear or aneurysm present

**Outcomes**
- **Untreated type A dissection mortality**: 1-2% per hour in first 48 hours, 50% at 48 hours, 90% at 1 month
- **Operative mortality**: 10-25%
- **Complications**: Stroke (5-10%), bleeding, renal failure, paraplegia

**Type B Dissection**

**Uncomplicated Type B (Medical Management)**
- **Indications for medical management**: Stable, no malperfusion, no rupture
- **Medical therapy**:
  - **Anti-impulse therapy**: Beta-blockers (target HR <60, SBP 100-120 mmHg)
  - **Pain control**
  - **ICU monitoring** × 24-48 hours
  - **Serial imaging**: CTA at discharge, 1 month, 3 months, 6 months, then annually
- **Outcomes**: 90% survival at 30 days with medical management

**Complicated Type B (Surgical/Endovascular Intervention)**

**Indications**
- **Rupture** or impending rupture (contained rupture, expanding periaortic hematoma)
- **Malperfusion syndromes**: Visceral, renal, limb ischemia
- **Refractory hypertension**
- **Persistent pain** despite medical therapy
- **Rapid aortic expansion**

**TEVAR (Preferred for Complicated Type B)**
- **Goal**: Cover proximal intimal tear, promote false lumen thrombosis, restore true lumen flow
- **Technique**: Similar to TEVAR for aneurysm; stent-graft covers entry tear
- **Adjuncts for malperfusion**:
  - **Fenestration**: Create communication between true and false lumen (equalize pressures)
  - **Branch vessel stenting**: Restore perfusion to compromised visceral/renal arteries

**Open Repair (Rarely Used for Acute Type B)**
- **Indications**: TEVAR not feasible (anatomy), failed TEVAR
- **Higher morbidity/mortality** vs. TEVAR

**Outcomes**
- **Complicated type B mortality**: 30-50% without intervention
- **TEVAR for complicated type B**: 10-15% mortality, reduces late aneurysm formation

**Chronic Dissection**
- **Definition**: >2 weeks from onset
- **Management**: Medical therapy, surveillance imaging
- **Aneurysmal degeneration**: False lumen dilatation (20-40% at 5 years)
  - Indications for repair: ≥6.0 cm (≥5.5 cm in connective tissue disorder)
  - TEVAR or open repair

## Traumatic Aortic Injury

### Mechanism

- Blunt trauma: Motor vehicle collision, fall from height
- **Deceleration injury**: Shear force at aortic isthmus (ligamentum arteriosum, junction of mobile arch and fixed descending aorta)

### Diagnosis

- **CTA**: Gold standard
- Findings: Pseudoaneurysm, intimal flap, periaortic hematoma

### Management

**Grade I-II (Intimal Tear, Small Hematoma)**
- **Medical management**: Anti-impulse therapy, observation

**Grade III-IV (Pseudoaneurysm, Large Tear)**
- **Repair indicated**: Prevent rupture
- **TEVAR preferred**: Less invasive, avoid thoracotomy in polytrauma patient
- **Timing**: Urgent (not necessarily emergent); stabilize other life-threatening injuries first

### Outcomes

- **TEVAR mortality**: <5%
- Long-term surveillance: Endoleak, stent-graft migration (especially in young patients with growth)

## Postoperative Management

### Immediate Postoperative

**Hemodynamic Management**
- **Blood pressure control**: Avoid hypertension (stress on suture lines, risk of bleeding)
  - Target SBP <120 mmHg, MAP 70-80 mmHg
  - Beta-blockers, vasodilators
- **Cardiac output optimization**: Inotropes if low output
- **Bleeding**: Monitor chest tube output, coagulopathy correction, re-exploration if needed

**Neurologic Monitoring**
- **Stroke risk**: Frequent neuro checks, immediate imaging if deficits
- **Spinal cord ischemia**: Motor/sensory exams (wake patient early after descending/thoracoabdominal repair)
  - **Delayed paraplegia**: Can occur 24-48 hours post-op
  - **CSF drainage**: Continue × 48-72 hours, target CSF pressure <10 mmHg

**Renal Function**
- Monitor urine output, creatinine
- Avoid nephrotoxins
- Optimize hemodynamics

**Respiratory Care**
- Prolonged ventilation common after open thoracic/thoracoabdominal repair
- Aggressive pulmonary toilet

### Intermediate and Long-Term

**Anti-Impulse Therapy**
- **Lifelong beta-blockers**: Reduce aortic wall stress, slow aneurysm growth, prevent dissection extension
- **Blood pressure control**: Target SBP <120 mmHg

**Surveillance Imaging**
- **CT or MRI**: Post-discharge, 6 months, annually (or more frequent if abnormalities)
- Monitor: Graft integrity, aneurysm formation, dissection extension, endoleak (after TEVAR)

**Activity Restrictions**
- Avoid heavy lifting, straining (increase blood pressure)
- Marfan, Loeys-Dietz: Avoid contact sports, isometric exercise

## Key Points

1. **Ascending aortic aneurysm** ≥5.5 cm (≥5.0 cm in Marfan/BAV) is an indication for elective repair; untreated rupture carries >50% mortality.

2. **Type A aortic dissection** is a surgical emergency with 1-2% mortality per hour in first 48 hours; operative mortality is 10-25% but untreated mortality is 90% at 1 month.

3. **Type B aortic dissection** is initially managed medically with anti-impulse therapy (beta-blockers, target HR <60, SBP 100-120 mmHg); complicated type B (rupture, malperfusion) requires TEVAR or open repair.

4. **Valve-sparing root replacement (David procedure)** is preferred in younger patients with aortic root aneurysms and normal aortic valves, avoiding prosthetic valve complications; 85-90% freedom from reoperation at 10 years.

5. **Aortic arch surgery** requires cerebral protection strategies; antegrade cerebral perfusion (ACP) with moderate hypothermia (24-28°C) is preferred over deep hypothermic circulatory arrest alone (lower stroke risk).

6. **TEVAR (thoracic endovascular aortic repair)** has lower perioperative morbidity/mortality than open repair for descending thoracic aneurysms but requires lifelong surveillance for endoleaks and reintervention (10-20% at 5 years).

7. **Spinal cord ischemia** (paraplegia) complicates 5-15% of thoracoabdominal aortic repairs; risk reduced by CSF drainage, intercostal artery reimplantation, distal aortic perfusion, and motor evoked potential monitoring.

8. **Marfan syndrome** and **Loeys-Dietz syndrome** require aggressive surgical management with lower size thresholds (≥5.0 cm ascending aorta, ≥4.5 cm in Loeys-Dietz) and lifelong beta-blocker therapy.

9. **Endoleak** after TEVAR: Type I and III require reintervention; Type II is often benign and observed; risk factors include inadequate landing zones, severe angulation, and mural thrombus.

10. **Traumatic aortic injury** from blunt deceleration trauma typically occurs at the aortic isthmus; TEVAR is preferred over open repair with <5% mortality, but requires long-term surveillance especially in young patients.

## References

1. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease. Circulation. 2010;121(13):e266-369.

2. Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35(41):2873-2926.

3. David TE, Feindel CM, Webb GD, et al. Long-term results of aortic valve-sparing operations for aortic root aneurysm. J Thorac Cardiovasc Surg. 2006;132(2):347-354.

4. Svensson LG, Crawford ES, Hess KR, et al. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg. 1993;17(2):357-368.

5. Bavaria JE, Appoo JJ, Makaroun MS, et al. Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial. J Thorac Cardiovasc Surg. 2007;133(2):369-377.

6. Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897-903.

7. Nienaber CA, Rousseau H, Eggebrecht H, et al. Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial. Circulation. 2009;120(25):2519-2528.

8. Coselli JS, Bozinovski J, LeMaire SA. Open surgical repair of 2286 thoracoabdominal aortic aneurysms. Ann Thorac Surg. 2007;83(2):S862-864.

9. Azizzadeh A, Keyhani K, Miller CC 3rd, et al. Blunt traumatic aortic injury: initial experience with endovascular repair. J Vasc Surg. 2009;49(6):1403-1408.

10. Patel HJ, Nguyen C, Diener AC, et al. Open arch reconstruction in the endovascular era: analysis of 721 patients over 17 years. J Thorac Cardiovasc Surg. 2011;141(6):1417-1423.
